Personalised medicine and population health: breast and ovarian cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Personalised medicine and population health: breast and ovarian cancer
Authors
Keywords
-
Journal
HUMAN GENETICS
Volume 137, Issue 10, Pages 769-778
Publisher
Springer Nature America, Inc
Online
2018-10-17
DOI
10.1007/s00439-018-1944-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is invasion a necessary step for metastases in breast cancer?
- (2018) Steven A. Narod et al. BREAST CANCER RESEARCH AND TREATMENT
- The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer
- (2018) Victoria Sopik et al. BREAST CANCER RESEARCH AND TREATMENT
- Consolidated principles for screening based on a systematic review and consensus process
- (2018) Mark J. Dobrow et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation
- (2018) Joanne Kotsopoulos et al. GYNECOLOGIC ONCOLOGY
- Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer
- (2018) Allison W. Kurian et al. JAMA Oncology
- Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer
- (2017) J. Brian Szender et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial
- (2017) Yiwey Shieh et al. JNCI-Journal of the National Cancer Institute
- Association analysis identifies 65 new breast cancer risk loci
- (2017) Kyriaki Michailidou et al. NATURE
- Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial
- (2017) Yiwey Shieh et al. JNCI-Journal of the National Cancer Institute
- The impact of an expanded genetic testing program and selective oophorectomy on the incidence of ovarian cancer in West Pomerania
- (2016) J. Menkiszak et al. CLINICAL GENETICS
- Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment
- (2016) Keith T. Schmidt et al. JOURNAL OF CLINICAL PHARMACOLOGY
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
- (2016) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial
- (2016) Tracy L. Stockley et al. Genome Medicine
- Inherited Mutations in Women With Ovarian Carcinoma
- (2016) Barbara M. Norquist et al. JAMA Oncology
- Impact of preventive therapy on the risk of breast cancer among women with benign breast disease
- (2015) Jack Cuzick et al. BREAST
- Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ
- (2015) Laura L. Reimers et al. Breast Journal
- Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer
- (2015) Jordan Lerner-Ellis et al. Expert Review of Anticancer Therapy
- Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
- (2015) Nasim Mavaddat et al. JNCI-Journal of the National Cancer Institute
- Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
- (2015) Jack Cuzick et al. LANCET ONCOLOGY
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
- (2015) Christophe Le Tourneau et al. LANCET ONCOLOGY
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
- (2015) Nasim Mavaddat et al. JNCI-Journal of the National Cancer Institute
- Tamoxifen Chemoprevention—End of the Road?
- (2015) Steven A. Narod JAMA Oncology
- Different Patterns in the Prognostic Value of Age for Breast Cancer-Specific Mortality Depending on Hormone Receptor Status: A SEER Population-Based Analysis
- (2014) Yi-Rong Liu et al. ANNALS OF SURGICAL ONCOLOGY
- Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers
- (2014) Joanne Kotsopoulos et al. BREAST CANCER RESEARCH AND TREATMENT
- Factors influencing ovulation and the risk of ovarian cancer inBRCA1andBRCA2mutation carriers
- (2014) Joanne Kotsopoulos et al. INTERNATIONAL JOURNAL OF CANCER
- Use of and Mortality After Bilateral Mastectomy Compared With Other Surgical Treatments for Breast Cancer in California, 1998-2011
- (2014) Allison W. Kurian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
- (2014) Amy P.M. Finch et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin in Prevention of Ovarian Cancer: Are We at the Tipping Point?
- (2014) D. Tsoref et al. JNCI-Journal of the National Cancer Institute
- Precision Medicine Meets Public Health: Population Screening for BRCA1 and BRCA2
- (2014) E. Levy-Lahad et al. JNCI-Journal of the National Cancer Institute
- Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
- (2014) Fabrice André et al. LANCET ONCOLOGY
- Abolishing Mammography Screening Programs? A View from the Swiss Medical Board
- (2014) Nikola Biller-Andorno et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preventing ovarian cancer through genetic testing: a population-based study
- (2013) A. Finch et al. CLINICAL GENETICS
- Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2013) Kelly-Anne Phillips et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of Asynchronous Contralateral Breast Cancer in Noncarriers ofBRCA1andBRCA2Mutations With a Family History of Breast Cancer: A Report From the Women's Environmental Cancer and Radiation Epidemiology Study
- (2012) Anne S. Reiner et al. JOURNAL OF CLINICAL ONCOLOGY
- The landscape of cancer genes and mutational processes in breast cancer
- (2012) Philip J. Stephens et al. NATURE
- Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
- (2012) Archie Bleyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer
- (2011) Shiyu Zhang et al. GYNECOLOGIC ONCOLOGY
- Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades
- (2011) László Tabár et al. RADIOLOGY
- High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing
- (2011) Nikhil Wagle et al. Cancer Discovery
- Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women
- (2009) Kelly A. Metcalfe et al. JOURNAL OF CLINICAL ONCOLOGY
- Beyond odds ratios — communicating disease risk based on genetic profiles
- (2009) Peter Kraft et al. NATURE REVIEWS GENETICS
- Uptake of clinical genetic testing for ovarian cancer in Ontario: A population-based study
- (2008) Kelly A. Metcalfe et al. GYNECOLOGIC ONCOLOGY
- International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
- (2008) Kelly A. Metcalfe et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome
- (2008) John Burn et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started